Skip to main content
Premium Trial:

Request an Annual Quote

Biological Dynamics' ExoVita Pancreas

Biological Dynamics said this week that it has validated and launched a laboratory-developed test, ExoVita Pancreas, through the company's CLIA-certified and CAP-accredited lab. The firm's assay platform involves isolation of exosomes with particular protein biomarkers from a standard blood sample, in this case to detect stage 1 and stage 2 pancreatic ductal adenoma carcinomas.

Biological Dynamics said that it intends to further validate the assay in a trial called ExoLuminate, which is currently enrolling patients with a high risk for pancreatic cancer. Eligible patients include those with a known familial or genetic predisposition, or certain clinical symptoms.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.